{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:22:31Z","timestamp":1759742551645},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.intimp.2004.10.004","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T01:41:18Z","timestamp":1103161278000},"page":"315-330","source":"Crossref","is-referenced-by-count":16,"title":["T cells recognize PD(N\/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1"],"prefix":"10.1016","volume":"5","author":[{"given":"Vladimir M.","family":"Pisarev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Kinarsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz-George","family":"Hanisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2004.10.004_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/07391102.1995.10508837","article-title":"Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope","volume":"13","author":"Fontenot","year":"1995","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.intimp.2004.10.004_bib2","doi-asserted-by":"crossref","first-page":"18165","DOI":"10.1074\/jbc.274.26.18165","article-title":"High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells","volume":"274","author":"Muller","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2004.10.004_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/glycob\/10.5.439","article-title":"MUC1: the polymorphic appearance of a human mucin","volume":"10","author":"Hanisch","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.intimp.2004.10.004_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib5","first-page":"425","article-title":"Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma","volume":"14","author":"Nakagawa","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2004.10.004_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.V93.4.1287","article-title":"Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone","volume":"93","author":"Treon","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2004.10.004_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000011969","article-title":"MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression","volume":"56","author":"Tanimoto","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.intimp.2004.10.004_bib8","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood.V95.8.2666","article-title":"MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets","volume":"95","author":"Dyomin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2004.10.004_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1020360121451","volume":"7","author":"Taylor-Papadimitriou","year":"2002","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.intimp.2004.10.004_bib10","first-page":"4287","article-title":"Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study","volume":"17","author":"Croce","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<311::AID-PATH917>3.0.CO;2-2","article-title":"Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours","volume":"183","author":"Dong","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2004.10.004_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-065X.1995.tb00077.x","article-title":"MUC-1 epithelial tumor mucin-based immunity and cancer vaccines","volume":"145","author":"Finn","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2004.10.004_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3835(94)03673-7","article-title":"The immunogenicity of MUC1 peptides and fusion protein","volume":"90","author":"Apostolopoulos","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2004.10.004_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002620050254","article-title":"The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine","volume":"42","author":"Graham","year":"1996","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib15","first-page":"1693","article-title":"Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21","volume":"6","author":"Gilewski","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00262-002-0317-z","article-title":"Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I\/II clinical trial","volume":"51","author":"Pecher","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0215(19980119)75:2<295::AID-IJC20>3.0.CO;2-B","article-title":"Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine","volume":"75","author":"Samuel","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib18","first-page":"3315","article-title":"Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice","volume":"56","author":"Zhang","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<660::AID-IJC24>3.0.CO;2-E","article-title":"Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4","volume":"71","author":"Gold","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ijc.1613","article-title":"Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer","volume":"97","author":"Cardillo","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib21","first-page":"693","article-title":"Targeted therapy of cancer with radiolabeled antibodies","volume":"43","author":"Goldenberg","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.intimp.2004.10.004_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1040-8428(00)00136-0","article-title":"Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies","volume":"38","author":"Richman","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.intimp.2004.10.004_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.bjc.6601267","article-title":"An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells","volume":"89","author":"Heuser","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002371-199701000-00004","article-title":"Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7","volume":"20","author":"Akagi","year":"1997","journal-title":"J. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<664::AID-IJC17>3.0.CO;2-7","article-title":"Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells","volume":"65","author":"Graham","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/bc970183n","article-title":"Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses","volume":"9","author":"Guan","year":"1998","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2004.10.004_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002620100212","article-title":"Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1)","volume":"50","author":"Johnen","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1023\/A:1021332932531","article-title":"Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases","volume":"19","author":"Kamata","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.intimp.2004.10.004_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.cgt.7700444","article-title":"Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model","volume":"9","author":"Kontani","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2004.10.004_bib30","first-page":"493","article-title":"Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin","volume":"12","author":"Kontani","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2004.10.004_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ijc.1286","article-title":"Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients","volume":"93","author":"Snijdewint","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib32","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.1830271017","article-title":"MUC1 peptide epitopes associated with five different H-2 class I molecules","volume":"27","author":"Apostolopoulos","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib33","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies","volume":"93","author":"Brossart","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2004.10.004_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-2776(04)82006-6","article-title":"MUC1 immunobiology: from discovery to clinical applications","volume":"82","author":"Vlad","year":"2004","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01789125","article-title":"Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene","volume":"36","author":"Ding","year":"1993","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib36","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.4049\/jimmunol.155.10.4766","article-title":"Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin","volume":"155","author":"Domenech","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00002371-200201000-00005","article-title":"Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope","volume":"25","author":"Heukamp","year":"2002","journal-title":"J. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<702::AID-IJC16>3.0.CO;2-1","article-title":"Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides","volume":"86","author":"von Mensdorff-Pouilly","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<875::AID-IJC18>3.0.CO;2-1","article-title":"Mouse mucin 1 (MUC1) defined by monoclonal antibodies","volume":"76","author":"Xing","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2004.10.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000056500","article-title":"Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17\u201323, 1996","volume":"19","author":"Price","year":"1998","journal-title":"Tumour Biol."},{"key":"10.1016\/j.intimp.2004.10.004_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<391::AID-IJC16>3.0.CO;2-V","article-title":"Novel breast-tumor-associated MUC1-derived peptides: characterization in Db\u2212\/\u2212 x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1\/Db-beta2 microglobulin single chain","volume":"85","author":"Carmon","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1051>3.0.CO;2-Z","article-title":"Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2\/K(b)-transgenic mice","volume":"91","author":"Heukamp","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.20040","article-title":"Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8+ and CD4+ T cells but does not require the MUC1 tandem repeat domain","volume":"109","author":"Plunkett","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib44","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/1078-0432.CCR-1011-03","article-title":"A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1","volume":"10","author":"Tsang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1089\/107999099312830","article-title":"Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization","volume":"19","author":"Lees","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002371-200301000-00006","article-title":"Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer","volume":"26","author":"Mukherjee","year":"2003","journal-title":"J. Immunother."},{"key":"10.1016\/j.intimp.2004.10.004_bib47","first-page":"829","article-title":"Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy","volume":"6","author":"Karanikas","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib48","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.4049\/jimmunol.160.7.3163","article-title":"Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery","volume":"160","author":"Sandberg","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib49","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/jm00045a023","article-title":"Agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activities","volume":"37","author":"Sanderson","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2004.10.004_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1399-3011.1999.00087.x","article-title":"Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin","volume":"54","author":"Vogen","year":"1999","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/0929867013373156","article-title":"Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations","volume":"8","author":"Taylor","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2004.10.004_bib52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4049\/jimmunol.158.3.1377","article-title":"Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin","volume":"158","author":"Tempero","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib53","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.4049\/jimmunol.164.10.5492","article-title":"Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant","volume":"164","author":"Ulrich","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1567-5769(02)00260-6","article-title":"Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant","volume":"3","author":"Sanderson","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2004.10.004_bib55","article-title":"Tumor-associated antigens identified by mRNA expression profiling as tumor rejection epitopes","author":"Andersen","year":"2003","journal-title":"J. Immune"},{"key":"10.1016\/j.intimp.2004.10.004_bib56","first-page":"6523","article-title":"Full-length dominant-negative survivin for cancer immunotherapy","volume":"9","author":"Pisarev","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib57","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/S0264-410X(02)00096-8","article-title":"Flt3 ligand and conjugation to IL-1beta peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine","volume":"20","author":"Pisarev","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2004.10.004_bib58","first-page":"285","article-title":"Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer","volume":"9","author":"Yu","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2004.10.004_bib59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0192-0561(00)00048-5","article-title":"Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine","volume":"22","author":"Pisarev","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.intimp.2004.10.004_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-2836(91)90567-P","article-title":"Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution","volume":"219","author":"Saper","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2004.10.004_bib61","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1073\/pnas.89.17.8403","article-title":"Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition","volume":"89","author":"Zhang","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2004.10.004_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0092-8674(94)90171-6","article-title":"The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection","volume":"76","author":"Young","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2004.10.004_bib63","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.159.11.5211","article-title":"Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen","volume":"159","author":"Apostolopoulos","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.161.2.767","article-title":"Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H-2 and HLA molecules","volume":"161","author":"Apostolopoulos","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/jmbi.1998.2209","article-title":"Crystal structure at 1.95 A resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition","volume":"284","author":"Dokurno","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2004.10.004_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0959-8049(93)90181-E","article-title":"Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes","volume":"29A","author":"Briggs","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2004.10.004_bib67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2567.1996.d01-701.x","article-title":"Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells","volume":"89","author":"Morelli","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2004.10.004_bib68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4757-9966-8_23","article-title":"Functional expression and modulation of C5a receptor (CD88) on skin dendritic cells","volume":"417","author":"Morelli","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2004.10.004_bib69","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-2567.2001.01197.x","article-title":"Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin","volume":"103","author":"Kirchhoff","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2004.10.004_bib70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2003.01764.x","article-title":"Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2","volume":"110","author":"Weinmann","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2004.10.004_bib71","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.4049\/jimmunol.171.5.2631","article-title":"Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-alpha and prostaglandin E2-dependent mechanisms","volume":"171","author":"Soruri","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.10.004_bib72","first-page":"557","article-title":"Enhanced antitumor immunostimulatory effects of human dendritic cells primed with conformationally biased response-selective C5a agonist decapeptide","volume":"vol. 44","author":"Joshi","year":"2003"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904003224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904003224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:49:43Z","timestamp":1682894983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576904003224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1567576904003224"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2004.10.004","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}